Home » Tenders » Europe » Poland » Delivery of Medicinal Products Tender, Poland - 98808147

Delivery of Medicinal Products Tender, Poland - 98808147

UNIVERSITY CLINICAL CENTER PROF. K. GIBIŃSKI MEDICAL UNIVERSITY OF SILESIA IN KATOWICE has floated a tender for Delivery of Medicinal Products. The project location is Poland and the tender is closing on 26 Mar 2024. The tender notice number is 157309-2024, while the TOT Ref Number is 98808147. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : Poland

Summary : Delivery of Medicinal Products

Deadline : 26 Mar 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 98808147

Document Ref. No. : 157309-2024

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Purchaser : UNIVERSITY CLINICAL CENTER PROF. K. GIBIŃSKI MEDICAL UNIVERSITY OF SILESIA IN KATOWICE
Address: ul. Ceglana 35
Town: Katowice
NUTS-Code: PL22A
Postal Code: 40-514
Phone: 32 358 1442
Poland
Email :acholuj@uck.katowice.pl
URL :https://www.uck.katowice.pl/

Tender Details

Delivery of medicinal products divided into 33 parts

Part 1 - Formulated substances

Part 1 - Formulated substances - specification and quantitative assortment specified in Annex 4.1 SWZ

Part 2 - Immunoglobulin 1

Part 2 - Immunoglobulin I - specification and quantitative assortment specifiedincluded in Annex 4.2 SWZ

Part 3 - Trabectedin

Part 3 - Trabectedin - specification and quantitative specification are specified in Annex 4.3 SWZ

Part 4 - Bevacizumab

Part 4 - Bevacizumab - specification and quantitative specification are specified in Annex 4.4 SWZ

Part 5 - Lanreotide

Part 5 - Lanreotide - product and quantity specification is specified in Annex 4.5 SWZ

Part 6 - Aflibercept

Part 6 - Aflibercept - product and quantity specification is specified in Annex 4.6 SWZ

Part 7 - Dexamethasonum

Part 7 - Dexamethasonum - product and quantity specification okare specified in Annex 4.7 SWZ

Part 8 - Pasireotide

Part 8 - Pasireotide - specification and quantitative specification are specified in Annex 4.8 SWZ

Part 9 - Miscellaneous drugs

Part 9 - Miscellaneous drugs - specification and quantitative assortment are specified in Annex 4.9 SWZ

Part 10 - Immunoglobulinm II

Part 10 - Immunoglobulinum II - product and quantity specification specified in Annex 4.10 SWZ

Part 11 - Propofolum

Part 11 - Propofolum - product and quantitative specification specified in Annex 4.11 SWZ

Part 12 - Botulinum toxin A

Part 12 - Botulinum toxin...
Document Type: Contract Notice
Reference Number: DZP.281.12A.2024
Contract Type: supplies
Authority Type: body-pl
Doc Title: Dostawa produktow leczniczych
Dispatch Date: 2024-03-14
Publish Date: 2024-03-15
Submission Date: 2024-03-26